{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 399974376
| IUPAC_name = 1-[diphenylmethyl]-4-[3-(2-phenyl-1,3-dioxolan-2-yl)propyl]piperazine
| image = Dotarizine.png
| width = 220

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA =  
| legal_UK =  
| legal_US =  
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 84625-59-2
| ATC_prefix = none
| ATC_suffix =  
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 2106316
| ChEBI = 138033
| PubChem = 55285
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = IO7663S6D3
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 49929

<!--Chemical data-->
| C=29 | H=34 | N=2 | O=2 
| molecular_weight = 442.592 g/mol
| smiles = C1CN(CCN1CCCC2(OCCO2)C3=CC=CC=C3)C(C4=CC=CC=C4)C5=CC=CC=C5
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI          = 1S/C29H34N2O2/c1-4-11-25(12-5-1)28(26-13-6-2-7-14-26)31-21-19-30(20-22-31)18-10-17-29(32-23-24-33-29)27-15-8-3-9-16-27/h1-9,11-16,28H,10,17-24H2
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey       = LRMJAFKKJLRDLE-UHFFFAOYSA-N

| synonyms = Dotarizine
}}

'''Dotarizine''' is a drug used in the treatment of [[migraine]],<ref>{{cite journal | last1 = Ruiz-Nuño | first1 = A | last2 = Villarroya | first2 = M | last3 = Cano-Abad | first3 = M | last4 = Rosado | first4 = A | last5 = Balfagón | first5 = G | last6 = López | first6 = MG | last7 = García | first7 = AG | title = Mechanisms of blockade by the novel migraine prophylactic agent, dotarizine, of various brain and peripheral vessel contractility | journal = European Journal of Pharmacology | volume = 411 | issue = 3 | pages = 289–99 | year = 2001 | pmid = 11164387 | doi=10.1016/S0014-2999(00)00897-9}}</ref> which acts as a [[calcium channel blocker]],<ref>{{cite journal | last1 = Ruiz-Nuño | first1 = A | last2 = Mayorgas | first2 = I | last3 = Hernández-Guijo | first3 = JM | last4 = Olivares | first4 = R | last5 = García | first5 = AG | last6 = Gandía | first6 = L | title = Antimigraine dotarizine blocks P/Q Ca2+ channels and exocytosis in a voltage-dependent manner in chromaffin cells | journal = European Journal of Pharmacology | volume = 481 | issue = 1 | pages = 41–50 | year = 2003 | pmid = 14637173 | doi=10.1016/j.ejphar.2003.09.013}}</ref> and also as an [[Antagonist (pharmacology)|antagonist]] at the [[5-HT2A receptor|5HT<sub>2A</sub>]] [[Receptor (biochemistry)|receptor]], and to a lesser extent at the 5HT<sub>1A</sub> and 5HT<sub>2C</sub> receptors.<ref>{{cite journal | last1 = Farré | first1 = M | last2 = Roset | first2 = PN | last3 = Llorente | first3 = M | last4 = Márquez | first4 = M | last5 = Albet | first5 = C | last6 = Pérez | first6 = JA | last7 = Herrero | first7 = E | last8 = Ortíz | first8 = JA | title = Clinical pharmacokinetics and tolerability of dotarizine in healthy subjects after single and multiple oral administration | journal = Methods and findings in experimental and clinical pharmacology | volume = 19 | issue = 5 | pages = 343–50 | year = 1997 | pmid = 9379783 }}</ref><ref>{{cite journal | last1 = Montiel | first1 = C | last2 = Herrero | first2 = CJ | last3 = García-Palomero | first3 = E | last4 = Renart | first4 = J | last5 = García | first5 = AG | last6 = Lomax | first6 = RB | title = Serotonergic effects of dotarizine in coronary artery and in oocytes expressing 5-HT2 receptors | journal = European Journal of Pharmacology | volume = 332 | issue = 2 | pages = 183–93 | year = 1997 | pmid = 9286620 | doi=10.1016/S0014-2999(97)01073-X}}</ref> The anti-migraine action is thought to be due to its action as a [[vasodilator]],<ref>{{cite journal | last1 = Kuridze | first1 = N | last2 = Gajkowska | first2 = B | last3 = Czernicki | first3 = Z | last4 = Jurkiewicz | first4 = J | last5 = Cervos-Navarro | first5 = J | title = The effect of Dotarizine--(Ca2+ channel blocker)--on vascular reactivity and ultrastructure of cerebral capillaries in animals subjected to anoxia | journal = Folia Neuropathologica | volume = 36 | issue = 2 | pages = 101–8 | year = 1998 | pmid = 9757621 }}</ref><ref>{{cite journal | last1 = Kuridze | first1 = N | last2 = Czernicki | first2 = Z | last3 = Jarus-Dziedzic | first3 = K | last4 = Jurkiewicz | first4 = J | last5 = Cervos-Navarro | first5 = J | title = Regional differences of cerebrovascular reactivity effected by calcium channel blocker - dotarizine | journal = Journal of the neurological sciences | volume = 175 | issue = 1 | pages = 13–6 | year = 2000 | pmid = 10785251 | doi = 10.1016/S0022-510X(00)00275-6 }}</ref> but it also has some [[anxiolytic]] effects<ref>{{cite journal | last1 = Petkov | first1 = VD | last2 = Belcheva | first2 = S | last3 = Konstantinova | first3 = E | title = Anxiolytic effects of dotarizine, a possible antimigraine drug | journal = Methods and findings in experimental and clinical pharmacology | volume = 17 | issue = 10 | pages = 659–68 | year = 1995 | pmid = 9053586 }}</ref> and blocks [[amnesia]] produced by [[Electroconvulsive therapy|electroconvulsive shock]] in animals.<ref>{{cite journal | last1 = Lazarova | first1 = M | last2 = Petkova | first2 = B | last3 = Petkov | first3 = VD | title = Effect of dotarizine on electroconvulsive shock or pentylenetetrazol-induced amnesia and on seizure reactivity in rats | journal = Methods and findings in experimental and clinical pharmacology | volume = 17 | issue = 1 | pages = 53–8 | year = 1995 | pmid = 7623521 }}</ref>

==References==
{{Reflist|2}}

{{Antimigraine preparations}}
{{Channelergics}}
{{Serotonergics}}
{{Piperazines}}

[[Category:Antimigraine drugs]]
[[Category:Calcium channel blockers]]
[[Category:Piperazines]]
[[Category:Ketals]]
[[Category:Serotonin antagonists]]


{{antihypertensive-stub}}
{{analgesic-stub}}